DYADIC INTERNATIONAL INC. - COMMON STOCK

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

01 May 2025 15:00:00 By Nasdaq GlobeNewswire

Dyadic to Present at World Vaccine Congress | Washington

16 Apr 2025 14:00:00 By Nasdaq GlobeNewswire

Dyadic Reports 2024 Year-End Financial Results and Business Updates

26 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

20 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

12 Mar 2025 16:00:00 By Nasdaq GlobeNewswire

Dyadic to Attend Multiple Industry Events in March

06 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

06 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

21 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

12 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

04 Nov 2024 16:30:00 By Nasdaq GlobeNewswire

Dyadic Expands Global Presence with Participation in Key Industry Events

09 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

23 Sep 2024 09:50:55 By Nasdaq GlobeNewswire

Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

13 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

30 Jul 2024 16:00:00 By Nasdaq GlobeNewswire

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

28 Jun 2024 08:30:00 By Nasdaq GlobeNewswire

Dyadic to Attend Industry Events in June

30 May 2024 16:30:00 By Nasdaq GlobeNewswire

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

14 May 2024 16:00:00 By Nasdaq GlobeNewswire

Dyadic to Attend Industry and Investor Events in May

08 May 2024 08:30:00 By Nasdaq GlobeNewswire

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

30 Apr 2024 16:30:00 By Nasdaq GlobeNewswire

Dyadic Reports 2023 Full Year Results and Recent Company Progress

28 Mar 2024 16:00:00 By Nasdaq GlobeNewswire